ASPERCREME LIDOCAINE WITH EUCALYPTUS ESSENTIAL OIL- lidocaine hcl cream 
Chattem, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Aspercreme Lidocaine with Eucalyptus Essential Oil

Aspercreme Lidocaine with Eucalyptus Essential Oil

Drug Facts

Active ingredient

Purpose

Lidocaine HCl 4%............................................................................................................................Topical anesthetic

Use

for the temporary relief of pain

Warnings

For external use only

Flammable: keep away from fire or flame.

Do not use 

 in large quantities 

 on wounds or on irritated or damaged skin

■ with a heating pad

When using this product

■ use only as directed

■ do not bandage tightly

■ avoid contact with eyes and mucous membranes

■ do not expose the area to local heat or to direct sunlight

Stop use and ask a doctor if

■ condition worsens or symptoms persist for more than 7 days

■ symptoms clear up and occur again within a few days

■ redness is present or excessive skin irritation occurs

■ you experience severe burning pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

■ adults and children 12 years of age and older:

      ■ apply a thin layer to affected area every 6 to 8 hours, not more than 3 to 4 times daily

      ■ massage until thoroughly absorbed into skin

      ■ wash hands thoroughly with soap and water after each use

■ children under 12 years of age: ask a doctor

Inactive ingredients

alcohol denat. (15%), aloe barbadensis leaf juice, C15-19 alkane, caprylic/capric triglyceride, carbomer, cetearyl alcohol, citric acid, ethylhexylglycerin, eucalyptus globulus leaf oil, glycerin, glyceryl stearate, hydroxyacetophenone, potassium hydroxide, polysorbate 60, propanediol, steareth-2, steareth-21, water

                                                                                 373-005

Child-resistant packaging. Close cap tightly after use.

Keep carton as it contains important information.

PRINCIPAL DISPLAY PANEL

Aspercreme
Lidocaine with Eucalyptus Essential Oil
Numbs away pain

NET WT 3 oz (85 g)

PRINCIPAL DISPLAY PANEL
Aspercreme
Lidocaine with Eucalyptus Essential Oil
Numbs away pain
NET WT 3 oz (85 g)

ASPERCREME LIDOCAINE WITH EUCALYPTUS ESSENTIAL OIL 
lidocaine hcl cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0566
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
C15-19 ALKANE (UNII: CI87N1IM01)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
EUCALYPTUS OIL (UNII: 2R04ONI662)  
GLYCERIN (UNII: PDC6A3C0OX)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
PROPANEDIOL (UNII: 5965N8W85T)  
STEARETH-2 (UNII: V56DFE46J5)  
STEARETH-21 (UNII: 53J3F32P58)  
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-0566-01 in 1 CARTON01/15/2023
185 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34801/15/2023
Labeler - Chattem, Inc. (003336013)

Revised: 12/2022
 
Chattem, Inc.